Focal nodular hyperplasia (FNH):: A potential cause of false-positive positron emission tomography

被引：16
作者：
Aznar, DL
Ojeda, R
Garcia, EU
Aparici, F
Sánchez, PA
Flores, D
Martínez, C
Sopena, R
机构：
[1] Hosp 12 Octubre, Dept Nucl Med, Valencia 46015, Spain
[2] Hosp 12 Octubre, Dept Radiol, Valencia 46015, Spain
[3] Hosp Dr Peset, Dept Nucl Med, Valencia, Spain
[4] Hosp La Fe, Dept Nucl Med, Valencia, Spain
来源：
CLINICAL NUCLEAR MEDICINE | 2005年 / 30卷 / 09期
关键词：
focal nodular hyperplasia; FDG-PET; false-positive;
D O I：
10.1097/01.rlu.0000174209.49753.a5
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Positron emission tomography (PET) using F-18 fluorodeoxyglucose (FDG) has been proven to be a useful tool in the differential diagnosis of liver tumors. Focal nodular hyperplasia (FNH) is an uncommon benign liver lesion, which can be difficult to differentiate from other benign and malignant liver pathologies. FDG PET imaging usually shows uptake similar or even decreased compared to that of the normal liver. We describe a hypermetabolic FNH lesion in a patient with a history of breast cancer. Computed tomography scan, ultrasonography (US), and magnetic resonance imaging were negative. The lesion was resected, and histologic findings were consistent with FNH. Copyright © 2005 by Lippincott Williams & Wilkins.
引用
收藏
页码：636 / 637
页数：2
相关论文
共 10 条
[1]   MRI of atypical focal nodular hyperplasia of the liver: Radiology-pathology correlation [J].
Ferlicot, S ;
Kobeiter, H ;
Van Nhieu, JT ;
Cherqui, D ;
Dhumeaux, D ;
Mathieu, D ;
Zafrani, ES .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2004, 182 (05) :1227-1231
[2]   Recent advances in imaging hepatocellular carcinoma: Diagnosis, staging and response assessment: Functional imaging [J].
Hain, SF ;
Fogelman, I .
CANCER JOURNAL, 2004, 10 (02) :121-127
[3]  
Ho CL, 2003, J NUCL MED, V44, P213
[4]   Focal nodular hyperplasia: Findings at state-of-the-art MR imaging, US, CT, and pathologic analysis [J].
Hussain, SM ;
Terkivatan, T ;
Zondervan, FE ;
Lanjouw, EE ;
de Rave, S ;
Ifzermans, JNM .
RADIOGRAPHICS, 2004, 24 (01) :3-17
[5]   Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors [J].
Iwata, Y ;
Shiomi, S ;
Sasaki, N ;
Jomura, H ;
Nishiguchi, S ;
Seki, S ;
Kawabe, J ;
Ochi, H .
ANNALS OF NUCLEAR MEDICINE, 2000, 14 (02) :121-126
[6]   An algorithm for the accurate identification of benign liver lesions [J].
Kim, J ;
Ahmad, SA ;
Lowy, AM ;
Buell, JF ;
Pennington, LJ ;
Moulton, JS ;
Matthews, JB ;
Hanto, DW .
AMERICAN JOURNAL OF SURGERY, 2004, 187 (02) :274-279
[7]   18F-Fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver [J].
Kurtaran, A ;
Becherer, A ;
Pfeffel, F ;
Müller, C ;
Traub, T ;
Schmaljohann, J ;
Kaserer, K ;
Raderer, M ;
Schima, W ;
Dudczak, R ;
Kletter, K ;
Virgolini, I .
LIVER, 2000, 20 (06) :487-490
[8]  
Mathieu D, 1997, Magn Reson Imaging Clin N Am, V5, P255
[9]   Two cases of focal nodular hyperplasia of the liver: Value of scintigraphy with Tc-99m GSA and positron emission tomography with FDG [J].
Shiomi, S ;
Kurooka, H ;
Iwata, Y ;
Sasaki, N ;
Masaki, K ;
Jomura, H ;
Nishiguchi, S ;
Kuroki, T ;
Ochi, H .
ANNALS OF NUCLEAR MEDICINE, 1999, 13 (06) :427-431
[10]  
Swingle CA, 2003, CLIN NUCL MED, V28, P134
1